Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDGN > SEC Filings for MDGN > Form 8-K/A on 17-Apr-2013All Recent SEC Filings

Show all filings for MEDGENICS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K/A for MEDGENICS, INC.


Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously reported in a Current Report on Form 8-K filed on March 14, 2013, in connection with the election of Joseph J. Grano, Jr. to the Board of Directors of Medgenics, Inc. (the "Company") on March 8, 2013 (effective as of March 15, 2013), the Compensation Committee of the Company's Board of Directors approved the grant to Mr. Grano of stock options covering up to 300,000 shares of the Company's common stock, $0.0001 par value per share ("Common Stock"), at a per share exercise price of $4.99 (representing the closing price of the Common Stock on the NYSE MKT on March 7, 2013, the date of the original approval of the grant by the Compensation Committee), subject to approval by the NYSE MKT of an additional listing application covering the issuance of the shares underlying such options. 100,000 shares underlying such options will vest upon grant and the remaining 200,000 shares will vest in equal installments on each of the first and second anniversaries of the effective date of Mr. Grano's appointment, subject to his continuous service through each vesting date. The options may only be exercised for cash and will expire on March 15, 2018. The grant was initially contemplated to be made pursuant to a stand-alone award agreement outside of the Company's Stock Incentive Plan (the "Plan").

On April 12, 2013, prior to approval by the NYSE MKT of the additional listing application, the Compensation Committee of the Company's Board of Directors determined instead to issue such options under the Plan. The terms of the options, including the number, exercise price, vesting schedule and expiration date, were the same as previously approved by the Compensation Committee on March 7, 2013.

  Add MDGN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDGN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.